Incyte Corp. (NASDAQ:INCY) shares traded 1.28% higher at $59.16 on Wall Street last session.
INCY stock price is now 7.21% away from the 50-day moving average and 1.88% away from the 200-day moving average. The market capitalization of the company currently stands at $13.30B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $55, Deutsche Bank recently initiated with Hold rating for Incyte Corp. (NASDAQ: INCY). , while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Stein Steven H, EVP & Chief Medical Officer sold 7,365 shares of the company’s stock on Jan 03 ’24. The stock was sold for $482,481 at an average price of $65.51. Upon completion of the transaction, the EVP & Chief Medical Officer now directly owns 90,218 shares in the company, valued at $5.34 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 02 ’24, EVP, GMAPPS Iyengar Vijay K sold 657 shares of the business’s stock. A total of $42,705 was realized by selling the stock at an average price of $65.00. This leaves the insider owning 43,412 shares of the company worth $2.57 million. A total of 1.72% of the company’s stock is owned by insiders.
During the past 12 months, Incyte Corp. has had a low of $50.27 and a high of $67.36. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 3.47, and a quick ratio of 3.43. According to the stock market information, the enterprise value for the company is $9470537728, which is based on a 17.96 price-to-earnings ratio, a 0.78 price-to-earnings-growth ratio, and a beta of 0.73. The fifty day moving average price for INCY is $55.2234 and a two-hundred day moving average price translates $58.04115 for the stock.
The latest earnings results from Incyte Corp. (NASDAQ: INCY) was released for 2024-03-31. The net profit margin was 19.78% and return on equity was 15.13% for INCY. The company reported revenue of $880.89 million for the quarter, compared to $808.67 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.93 percent.
